Previous Article | Next Article 
Journal of Clinical Microbiology, June 1999, p. 2016-2019, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Species-Specific Identification of
Mycobacterium leprae by PCR-Restriction Fragment Length
Polymorphism Analysis of the hsp65 Gene
Nalin
Rastogi,*
Khye
Seng
Goh, and
Mylene
Berchel
Unité de la Tuberculose et des
Mycobactéries, Institut Pasteur, 97165 Pointe à Pitre
Cedex, Guadeloupe
Received 22 January 1999/Returned for modification 15 February
1999/Accepted 3 March 1999
 |
ABSTRACT |
PCR-restriction fragment length polymorphism analysis (PRA) of the
hsp65 gene present in all mycobacteria was used in the present investigation to characterize Mycobacterium leprae.
Bacilli were extracted and purified from different organs from
experimentally infected armadillos and nude mice (Swiss mice of
nu/nu origin). A total of 15 samples were assayed in
duplicate, and the results were compared with those obtained for a
total of 147 cultivable mycobacteria representing 34 species.
Irrespective of its origin or viability, M. leprae strains
from all the samples were uniformly characterized by two fragments of
315 and 135 bp upon BstEII digestion and two fragments of
265 and 130 bp upon HaeIII digestion. PRA is a relatively
simple method and permits the conclusive identification of M. leprae to the species level.
 |
TEXT |
PCR-restriction fragment length
polymorphism analysis (PRA), which relies on the amplification of a
439-bp portion of the hsp65 gene present in all mycobacteria
(5, 9, 10), followed by two distinct digestions of the PCR
product, now offers a rapid and easy alternative that permits the rapid
identification of mycobacteria without the need for specialized
equipment (2, 12, 13). Recently, we have proposed a modified
PRA algorithm with characteristic BstEII and
HaeIII fragment lengths as a means for the rapid
identification of a total of 34 mycobacterial species (2).
In the present investigation, we attempted to use the same methodology
to investigate if it was possible to conclusively identify
Mycobacterium leprae, which is nonidentifiable by routine methodologies (11) and which remains the only noncultivable mycobacterial species.
The M. leprae bacteria were extracted and purified from
lepromas, livers, and spleens from experimentally infected armadillos (five animals) and footpads, lymph nodes, livers, and spleens from
Swiss nu/nu mice (five animals) as reported earlier (3, 7). The infected armadillo and nude mouse tissues were kindly provided by Y. Robin, Pasteur Institute of French Guyana, and C. C. Guelpa-Lauras, Medical Faculty of
Pitié-Salpêtrière Hospital, Paris, France,
respectively. Briefly, the infected tissues were manually ground with a
mortar and pestle in the presence of sterilized sand. The mixture was
centrifuged at 800 × g and 4°C to remove the larger
fragments of tissue, which were treated as described above two to three
times to further extract the bacteria. The pooled supernantants were
then centrifuged successively at 800 and 3,000 × g to
remove the sand plus tissue debris and the larger bacterial clumps,
respectively. The bacilli from the supernatant obtained after
centrifugation at 3,000 × g were recovered by
centrifugation at 10,000 × g and 4°C, thoroughly
washed to remove the tissue debris, treated with 4% (vol/vol)
H2SO4 for 10 min at room temperature, neutralized with NaOH, and washed three times. The purity of the bacteria at this step was controlled by Ziehl-Neelsen staining and
electron microscopy, and the absence of any microbiological contamination was confirmed by plating the bacterial suspension on the
usual growth media (7). The number of bacteria was
determined by counting the bacteria in 10 fields of 0.02 mm2 and obtaining an average, and the proportion of
solid-staining bacteria, expressed as a morphological index, was
determined as reported previously (14). The purified
bacteria were also characterized by the presence of tuberculostearic
acid and phenolic glycolipid-1, as described earlier (7).
The bacteria obtained were suspended in small aliquots and were frozen
at
80°C. For some experiments, the bacterial suspensions were
irradiated with gamma radiation at 106 rads.
A total of 15 M. leprae samples were assayed in duplicate,
and the results that were obtained (Table
1) were compared with those obtained for
a total of 147 cultivable mycobacteria comprising 43 reference strains
and 104 clinical isolates representing 34 species for which an
algorithm has recently been described (2). Bacterial DNA was
prepared by a microbead method as reported earlier (2), and
5 µl of the supernatant containing the crude DNA extract was used for
PCR with the primers Tb11 (5'-ACCAACGATGGTGTGTCCAT) and Tb12
(5'-CTTGTCGAACCGC-ATACCCT) by the procedure described by
Telenti et al. (13). The PCR amplified a 439-bp fragment of
the gene encoding for the 65-kDa heat shock protein. The amplification product was subjected to BstEII (Promega, Madison, Wis.) and
HaeIII (BioLabs, Inc., Beverly, Mass.) enzyme digestions,
and the fragments were electrophoresed on a 4% (wt/vol) NuSieve 3:1
agarose gel (FMC Bioproducts, Rockland, Maine) as reported previously
(2). A 100-bp ladder (Pharmacia Biotech, Uppsala, Sweden)
served as an external molecular size marker and was added after every
sixth lane of the gel to reduce migration-related errors. The fragments were visualized by ethidium bromide staining to observe the
fluorescence, videotaped by using a camera and Gel-Analyst software
(Gel-Analyst and Video-copy; Bioprobe Systems, Montreuil, France), and
stored in the TIFF format. The Taxotron software package (Institut
Pasteur, Paris, France) coupled to a Power MacIntosh 7200/90 (Apple
Computers, Cupertino, Calif.) was used to convert the migration file
into molecular mass data file by the Schaeffer and Sederoff method reported previously (2). As indicated previously
(13), restriction fragments shorter than 60 bp were not
taken into account because they are suspected to be primer or
primer-dimer bands. The sensitivity of the PRA method for M. leprae detection was assayed by adjusting the bacterial
suspensions to an optical density at 650 nm (OD650) of 0.15 (about 1 mg/ml) and performing serial dilutions that were subjected to
both acid-fast microscopy and PRA in parallel. Because M. leprae is a noncultivable species, to have an idea of the
sensitivity of the PRA method in terms of viable bacterial counts,
similar experiments were also performed in parallel with a clinical
isolate (isolate 97096) of Mycobacterium tuberculosis.
As summarized in Fig. 1 and Table 1, all
of the M. leprae suspensions, irrespective of their origins,
were uniformly characterized by two fragments of 315 and 135 bp upon
BstEII digestion and two fragments of 265 and 130 bp upon
HaeIII digestion. When subjected to PRA analysis,
gamma-irradiated M. leprae (five samples; Table 1) gave
similar results, indicating that this method is not affected by
bacterial viability. Similarly, the limit of sensitivity of PRA for the
detection of M. leprae was nearly identical to that for the
detection of M. tuberculosis (Fig.
2); all the samples initially adjusted to
contain 1 mg of bacteria/ml (OD650 of 0.15) gave a positive
PRA result up to a dilution of 10
4, which corresponded to
about (3.5 ± 2.5) × 103 CFU/ml for M. tuberculosis (about 4 ± 2 acid-fast bacilli [AFB]/10 fields) and (4.70 ± 1.95) × 103 bacilli/ml (about
12.5 ± 4.5 AFB/10 fields) for M. leprae. Because 100 µl of bacterial suspension mixed with an equal amount of TE (Tris-EDTA) buffer was used for DNA extraction and only 5 µl of this
suspension was finally used in the amplification reaction (2), it may be presumed that the minimal number of bacteria needed for a positive PRA result under our experimental conditions was
about 8 to 13 bacilli for both M. tuberculosis and M. leprae.

View larger version (100K):
[in this window]
[in a new window]
|
FIG. 1.
PRA gel after BstEII (A) and
HaeIII (B) digestion of a 439-bp DNA fragment amplified from
M. leprae bacilli isolated from various samples. Lanes m,
molecular weight marker; lanes 1 to 5, samples from armadillos AV, AP,
AJ, AU, and A10, respectively, calibrated to a 1:100 dilution; lanes 6 to 8, samples from nude mouse L1 calibrated to 1:100, 1:1,000, and
1:10,000 dilutions, respectively; lanes 9 and 10, a sample from nude
mouse L1 that was purified to remove all host tissues and calibrated to
a 1:100 dilution compared to the dilution of the same sample run in
parallel as a partially purified preparation containing a significant
amount of host tissues; lanes 11 to 13, samples from armadillos AU, AV,
and AP, respectively, that were calibrated to 1:100 dilutions and that
were gamma irradiated with 106 rads; lanes 14 and 15, a
gamma-irradiated preparation from nude mouse L2 at 1:1,000 and 1:100
dilutions, respectively; lanes 16 to 18, gamma-irradiated preparations
from nude mice L4, L3, and L1, respectively, at a 1:100 dilutions. See
the text and Table 1 for details.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Sensitivity of PRA method for M. tuberculosis
(A) and M. leprae (B) detection. PRA was performed with
bacterial suspensions that were initially adjusted to an
OD650 of 0.15 (about 1 mg/ml) and that were serially
diluted 10-fold. The serially diluted suspensions were subjected to
both acid-fast microscopy and PRA in parallel. The numbers of CFU of
M. tuberculosis per milliliter were determined by plating
the suspensions on 7H11 agar medium and counting the bacterial colonies
after 21 days of incubation at 37°C. Due to the inability of M. leprae to grow in vitro, the number of bacilli per milliliter for
various 10-fold dilutions was estimated by measuring the bacterial
count in the initial sample by acid-fast microscopy, as indicated in
the text and Table 1, and then by assuming that the actual number of
bacilli in each of the dilutions was successively decreased 10-fold.
|
|
Because the armadillos were inoculated with bacilli from patients of
different geographical origins (Africa, South America, and Europe), the
identical restriction profiles for M. leprae from all
samples tested in this investigation suggest that M. leprae
is characterized by a specific PRA profile with bands of 315 and 135 bp
upon BstEII digestion and 265 and 130 bp upon
HaeIII digestion, which is in agreement with the published
sequence of the M. leprae 65-kDa antigen (5).
When these results were compared with those obtained for a total of 147 cultivable mycobacteria that included 34 mycobacterial species studied
recently by Devallois et al. (2), the PRA profile of
M. leprae upon BstEII digestion matched that for
the group that at present comprises only two other species, namely,
Mycobacterium haemophilum and Mycobacterium chelonaeI. However, on the basis of the results obtained by
HaeIII digestion, M. leprae (fragments of 265 and
130 bp) was unequivocally discriminated from both M. chelonaeI (which has a single fragment of 210 bp) and M. haemophilum (which has two fragments of 175 and 115 bp). It should
also be emphasized that the M. leprae-specific PRA pattern
was easily detected in five parallel samples that were exposed to
106 rads of gamma irradiation, as well as in an M. leprae-infected sample from the footpads of nude mice that was
only partially purified and that contained significant amounts of host
tissue (Table 1; Fig. 1). Hence, we conclude that the primers Tb11 and Tb12 used in this investigation selectively amplified the 439-bp portion of the mycobacterial hsp65 gene, irrespective of
M. leprae viability, and that the presence of host tissue
did not significantly interfere with the PRA results. This information
may be important in a clinical setting when this methodology is used
for the conclusive identification of M. leprae.
M. leprae is a noncultivable mycobacterium, and
consequently, the routine diagnosis of leprosy is still based on the
demonstration of at least two of the following observations: a
characteristic skin lesion, loss of sensation, a thickened nerve, or
the presence of AFB in smears of skin lesions (11).
Considering that the results of examinations such as smears and biopsy
may be erroneous, Talhari (11) recently concluded that,
"employing diagnostic tools that are currently available, it is
nearly impossible to state with certainty whether or not the patient
has leprosy, and one is faced with a difficult choice
to treat for
leprosy without a definitive diagnosis, or to follow the course of the
patient for a number of months while withholding treatment; neither is a very satisfactory alternative." In this context, the rapid
diagnosis of leprosy by molecular methods has found a renewed interest
among various scientific groups, and recently described methods include a variety of techniques such as amplification of M. leprae-specific repetitive sequences (15), in situ
hybridization (1), nested-primer gene amplification of a
347-bp product from a bacterial genomic library (6),
amplification of a 360-bp fragment of the 18-kDa protein gene
(8), or reverse transcription-PCR targeting the 16S rRNA of
M. leprae (4).
In the context of the information presented above, it was interesting
that the PRA methodology, which is easily applicable in a clinical
microbiology setting, was able to identify a variety of mycobacteria in
a single experiment (2, 17, 18). On the basis of the results
of the present study, which determined the PRA profiles of M. leprae from different geographical areas inoculated into two
experimental hosts (a total of 15 M. leprae-infected samples
were tested), we suggest that the methodology that we used is capable
of identifying M. leprae from any source or geographical origin by uniformly providing fragments of 315 and 135 bp upon BstEII digestion and 265 and 130 bp upon HaeIII
digestion. We conclude that PRA is particularly useful for the positive
identification of M. leprae, which still remains the only
noncultivable mycobacterium. Finally, the unique PRA profile obtained
for all M. leprae-infected samples tends to confirm the
genetic homogeneity of M. leprae species.
 |
ACKNOWLEDGMENTS |
We are grateful to the "Délégation
Générale au Réseau International des Instituts
Pasteur et Instituts Associés," Institut Pasteur, Paris,
France, and the Fondation Fran
aise Raoul Follereau, Paris,
France, for financial support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité de
la Tuberculose et des Mycobactéries, Institut Pasteur, Morne
Jolivière B. P. 484, 97165 Pointe à Pitre Cedex,
Guadeloupe. Phone: 590-893-881. Fax: 590-893-880. E-mail:
rastogi{at}ipagua.gp.
 |
REFERENCES |
| 1.
| Arnoldi, J., C. Schluter, M. Duchrow, L. Hubner, M. Ernst, A. Teske, H. D. Flad, J. Gerdes, and E. C. Böttger. Species-specific assessment of Mycobacterium
leprae in skin biopsies by in situ hybridization and polymerase
chain reaction. Lab. Invest. 66:618-623.
|
| 2.
|
Devallois, A.,
K. S. Goh, and N. Rastogi.
1997.
Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species.
J. Clin. Microbiol.
35:2969-2973[Abstract].
|
| 3.
|
Fréhel, C., and N. Rastogi.
1987.
Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event.
Infect. Immun.
55:2916-2921[Abstract/Free Full Text].
|
| 4.
|
Kurabachew, M.,
A. Wondimu, and J. J. Ryon.
1998.
Reverse transcriptase-PCR detection of Mycobacterium leprae in clinical specimens.
J. Clin. Microbiol.
36:1352-1356[Abstract/Free Full Text].
|
| 5.
|
Mehra, V.,
D. Sweetser, and R. A. Young.
1986.
Efficient mapping of protein antigenic determinants.
Proc. Natl. Acad. Sci. USA
83:7013-7017[Abstract/Free Full Text].
|
| 6.
|
Plikaytis, B. B.,
R. H. Gelber, and T. M. Shinnick.
1990.
Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay.
J. Clin. Microbiol.
28:1913-1917[Abstract/Free Full Text].
|
| 7.
|
Rastogi, N.,
S. Cadou, and R. Hellio.
1991.
Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labelling of ultrathin sections.
Int. J. Lepr.
59:278-291.
|
| 8.
|
Scollard, D. M.,
T. P. Gillis, and D. L. Williams.
1998.
Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States.
Am. J. Clin. Pathol.
109:642-646[Medline].
|
| 9.
|
Shinnick, T. M.
1987.
The 65-kilodalton antigen of Mycobacterium tuberculosis.
J. Bacteriol.
169:1080-1088[Abstract/Free Full Text].
|
| 10.
|
Shinnick, T. M.,
M. H. Vodkin, and J. C. Williams.
1988.
The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Eschericha coli GroEL protein.
Infect. Immun.
56:446-451[Abstract/Free Full Text].
|
| 11.
|
Talhari, S.
1996.
Diagnosis, classification and prognosis.
Int. J. Lepr. Other Mycobact. Dis.
64(Suppl. 1):S13-S15[Medline].
|
| 12.
|
Taylor, T. B.,
C. Patterson,
Y. Hale, and W. W. Safranek.
1997.
Routine use of PCR-restriction fragment length polymorphism analysis for identification of mycobacteria growing in liquid media.
J. Clin. Microbiol.
35:79-85[Abstract].
|
| 13.
|
Telenti, A.,
F. Marchesi,
M. Balz,
F. Bally,
E. C. Böttger, and T. Bodmer.
1993.
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.
J. Clin. Microbiol.
31:175-178[Abstract/Free Full Text].
|
| 14.
|
Waters, M. F. R., and R. J. W. Rees.
1962.
Changes in the morphology of Mycobacterium leprae in patients under treatment.
Int. J. Lepr. Other Mycobact. Dis.
30:266-277.
|
| 15.
|
Yoon, K. H.,
S. N. Cho,
M. K. Lee,
R. M. Abalos,
R. V. Cellona,
T. T. Fajardo, Jr.,
L. S. Guido,
E. C. Dela Cruz,
G. P. Walsh, and J. D. Kim.
1993.
Evaluation of polymerase chain reaction amplification of Mycobacterium leprae-specific repetitive sequences in biopsy specimens from leprosy patients.
J. Clin. Microbiol.
31:895-899[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, June 1999, p. 2016-2019, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lini, N., Shankernarayan, N. P., Dharmalingam, K.
(2009). Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases. J Med Microbiol
58: 753-759
[Abstract]
[Full Text]
-
Chen, H.-J., Tsai, J.-C., Chang, T.-C., Hung, W.-C., Tseng, S.-P., Hsueh, P.-R., Teng, L.-J.
(2008). PCR-RFLP assay for species and subspecies differentiation of the Streptococcus bovis group based on groESL sequences. J Med Microbiol
57: 432-438
[Abstract]
[Full Text]
-
Tsai, J.-C., Hsueh, P.-R., Lin, H.-M., Chang, H.-J., Ho, S.-W., Teng, L.-J.
(2005). Identification of Clinically Relevant Enterococcus Species by Direct Sequencing of groES and Spacer Region. J. Clin. Microbiol.
43: 235-241
[Abstract]
[Full Text]
-
Hoffmann, H., Roggenkamp, A.
(2003). Population Genetics of the Nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol.
69: 5306-5318
[Abstract]
[Full Text]
-
Konomi, N., Lebwohl, E., Mowbray, K., Tattersall, I., Zhang, D.
(2002). Detection of Mycobacterial DNA in Andean Mummies. J. Clin. Microbiol.
40: 4738-4740
[Abstract]
[Full Text]
-
Ucko, M., Colorni, A., Kvitt, H., Diamant, A., Zlotkin, A., Knibb, W. R.
(2002). Strain Variation in Mycobacteriummarinum Fish Isolates. Appl. Environ. Microbiol.
68: 5281-5287
[Abstract]
[Full Text]
-
da Silva Rocha, A., Werneck Barreto, A. M., Dias Campos, C. E., Villas-Boas da Silva, M., Fonseca, L., Saad, M. H., Degrave, W. M., Suffys, P. N.
(2002). Novel Allelic Variants of Mycobacteria Isolated in Brazil as Determined by PCR-Restriction Enzyme Analysis of hsp65. J. Clin. Microbiol.
40: 4191-4196
[Abstract]
[Full Text]
-
Teng, L.-J., Hsueh, P.-R., Tsai, J.-C., Chen, P.-W., Hsu, J.-C., Lai, H.-C., Lee, C.-N., Ho, S.-W.
(2002). groESL Sequence Determination, Phylogenetic Analysis, and Species Differentiation for Viridans Group Streptococci. J. Clin. Microbiol.
40: 3172-3178
[Abstract]
[Full Text]
-
Teng, L.-J., Hsueh, P.-R., Wang, Y.-H., Lin, H.-M., Luh, K.-T., Ho, S.-W.
(2001). Determination of Enterococcus faecalis groESL Full-Length Sequence and Application for Species Identification. J. Clin. Microbiol.
39: 3326-3331
[Abstract]
[Full Text]
-
Brunello, F., Ligozzi, M., Cristelli, E., Bonora, S., Tortoli, E., Fontana, R.
(2001). Identification of 54 Mycobacterial Species by PCR-Restriction Fragment Length Polymorphism Analysis of the hsp65 Gene. J. Clin. Microbiol.
39: 2799-2806
[Abstract]
[Full Text]
-
Kim, B.-J., Lee, K.-H., Park, B.-N., Kim, S.-J., Bai, G.-H., Kim, S.-J., Kook, Y.-H.
(2001). Differentiation of Mycobacterial Species by PCR-Restriction Analysis of DNA (342 Base Pairs) of the RNA Polymerase Gene (rpoB). J. Clin. Microbiol.
39: 2102-2109
[Abstract]
[Full Text]